Clinical trials: Refractive Surgery

1 study

Ectasia
Corneal Collagen Cross-Linking for Ectasia (CXL)
- Completed
- Age: 14 years and older
- Phase 3
- Medical device
- Results posted
Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery.
Trial name
CXL (NCT00674661)
Testing
riboflavin ophthalmic solution, UVA Irradiation
Where
10 sites in United States
Volunteers
130 people
Sponsor
Glaukos Corporation
Can I take part? CXLUpdated 26 Apr 2021